Literature DB >> 7647980

Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.

S Palea1, M Corsi, J M Rimland, D G Trist.   

Abstract

1. In order to characterize the neuropeptide Y (NPY) Y1 receptors known to be present in rabbit isolated vas deferens and saphenous vein, the pharmacological activity of the selective NPY Y1 receptor agonists, [Leu31,Pro34] NPY and various other peptide agonists, together with the putative NPY antagonist, benextramine, were compared in the two tissues. 2. In rabbit isolated saphenous vein, cumulative dose-response curves to various NPY agonists were obtained. All the peptides tested caused contractions which developed quite slowly. The rank order of potency obtained was: PYY > NPY > [Leu31,Pro34] NPY = NPY2-36 > hPP >> NPY13-36 = NPY18-36. Incubation with benextramine (BXT) at 100 microM for 30 min irreversibly abolished the contractile response to [Leu31,Pro34] NPY but was ineffective against NPY18-36-induced contractions. 3. Cumulative dose-response curves to [Leu31,Pro34] NPY were performed in the same preparation before and after incubation with 100 microM BXT for 20 min in order to inactivate NPY Y1 receptors. The pKA (-logKA) estimation for [Leu31,Pro34] NPY was 7.60 +/- 0.30 using the operational model and 7.20 +/- 0.33 using the null method; the difference between the two methods was not statistically significant (P = 0.36). 4. Prostatic segments of rabbit vas deferens were electrically stimulated with single pulses. Immediately after stabilization of the contractile response, a cumulative dose-response curve to various NPY agonists was obtained in each tissue. The rank order of potency for twitch inhibition was: PYY> [Leu31,Pro34]NPY > NPY > hPP>NPY2- 36 >>NPY13-36>> NPY 18-36 which indicates the presence of a prejunctional NPY Y1 receptor. BXT at 100 microM incubated for 10 or 60 min did not antagonize the response to[Leu31,Pro34] NPY.5. We conclude that rabbit isolated saphenous vein contains a population of post-junctional NPY Y1 receptors irreversibly blocked by BXT, as well as a population of post-junctional NPY Y2 receptors,which are insensitive to BXT. In contrast, the rabbit isolated vas deferens express a pre-junctional NPYY1 receptor subtype which is not blocked by BXT. Tetramine disulphides such as BXT could be useful tools in classifying NPY receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647980      PMCID: PMC1908753          DOI: 10.1111/j.1476-5381.1995.tb16311.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Different neuropeptide Y receptor subtypes in rat and rabbit vas deferens.

Authors:  H N Doods; J Krause
Journal:  Eur J Pharmacol       Date:  1991-10-29       Impact factor: 4.432

Review 2.  Neuronal ATP receptors and their mechanism of action.

Authors:  P Illes; W Nörenberg
Journal:  Trends Pharmacol Sci       Date:  1993-02       Impact factor: 14.819

Review 3.  Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?

Authors:  C Wahlestedt; D J Reis
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

4.  Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.

Authors:  M C Michel; W Gaida; A G Beck-Sickinger; H A Wieland; H Doods; H Dürr; G Jung; G Schnorrenberg
Journal:  Mol Pharmacol       Date:  1992-10       Impact factor: 4.436

5.  The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype.

Authors:  A Cadieux; L H Pheng; S St-Pierre; A Fournier; M T Benchekroun
Journal:  Regul Pept       Date:  1993-07-23

6.  Neuropeptide Y and pancreatic polypeptide reduce calcium currents in acutely dissociated neurons from adult rat superior cervical ganglia.

Authors:  S Foucart; D Bleakman; V P Bindokas; R J Miller
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

Review 7.  Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms.

Authors:  L Grundemar; R Håkanson
Journal:  Gen Pharmacol       Date:  1993-07

8.  Benextramine-neuropeptide Y (NPY) binding site interactions: characterization of 3H-NPY binding site heterogeneity in rat brain.

Authors:  M B Doughty; K Li; L Hu; S S Chu; R Tessel
Journal:  Neuropeptides       Date:  1992-11       Impact factor: 3.286

9.  Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.

Authors:  R E Tessel; D W Miller; G A Misse; X Dong; M B Doughty
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

10.  Characterization of vascular neuropeptide Y receptors.

Authors:  L Grundemar; S E Jonas; N Mörner; E D Högestätt; C Wahlestedt; R Håkanson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

View more
  3 in total

1.  Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.

Authors:  A P Serone; C E Wright; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.

Authors:  K Obrietan; A N van den Pol
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

3.  Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.

Authors:  S Palea; M Corsi; J M Rimland; D G Trist; E Ratti
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.